Quaratusugene ozeplasmid

奥米奎基

Report date: 2024/09/19 15:03:42

Base Information

Drug NameQuaratusugene ozeplasmid
Drug Alias NameCholesterol-Fus1脂质体复合物DOTAP:Chol-fus1Nanoparticle formulation FUS-1FUS1 cancer gene therapyFUS1-DOTAP:cholesterol +[19] 
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionTumour suppressor candidate 2 gene transference
TargetsTumour suppressor candidate 2
Therapy Area/IndicationsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell LungLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesGenprex Inc
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsCarcinoma, Non-Small-Cell LungLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A